UnitedHealth director Noseworthy gets 240 stock units
A UnitedHealth Group director's deferred stock units vested immediately but must be retained until completion of service on the Board.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
UnitedHealth Group (UNH) director John H. Noseworthy acquired 240 deferred stock units on October 1, 2026, as regular quarterly compensation for director service. His reported direct holdings after the transaction were 7,902 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 240 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.
Key Figures
Key Terms
deferred stock units financial
immediately vested financial
quarterly compensation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many deferred stock units did UNH director John H. Noseworthy receive?
When can John H. Noseworthy retain or dispose of his UNH deferred stock units?
AI-generated analysis. How Rhea-AI works. Not financial advice.